Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cellsErin R. Scheidemann, Ayesha N. Shajahan‐Haq|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 2